Pharmaceutical Patient Adherehence and Disease Management

Summary

Increase the effectiveness of your patient adherence and disease management programs:

This report provides benchmarks for patient adherence and disease management organizational structures, resource investments, tactics and improvement processes. Explore some of the industry's most innovative programs, from leadership involvement to budgets to common program challenges.

Pharmaceutical Patient Adherence and Disease Management is designed in a reader-friendly format so you can easily access information according to interest and need. The report is broken down into four chapters:

• Structures, Headcounts and Investment - Learn how industry leaders draw on multiple functions to develop well-rounded campaigns. Explore timing of team assembly and investment levels of various programs.
• Program Management - Discover how the most successful programs rely on market research to develop customized messages and launch targeted efforts across various media channels. Study companies' strategies to achieve patient buy-in and overcome program challenges.
• Opportunity and Improvement - Investigate the business opportunity of addressing non-adherence. Uncover companies' strategies and tactics to improve their initiatives and the latest innovations on the adherence front.
• Real-World Program Details - Analyze real-world programs' resources, compliance rates, development timeframes and media mixes.

Utilize this report to win additional resource support for your patient adherence and disease management efforts. Apply findings from the report to streamline program management and improvement processes.

Contents

• Metrics Overview
• The following Is A List of Metrics Included in Pharmaceutical Patient Adherence and Disease Management. While This List Is Not Inclusive of All The Data in The Report, IT Summarizes The Main Categories and Types of Data Included in Each Chapter.
• Chapter 1:
  • Percentage of companies' portfolios supported by patient adherence programs
  • Percentage of companies' portfolios supported by disease management programs
  • Functions involved in program development and maintenance
  • Program team leadership
  • Team sizes throughout program launch and maintenance
  • Lifecycle stage in which companies assemble program teams
  • Percentage of programs' development budgets that are outsourced
  • Percentage of companies outsourcing specific program activities
  • Investment in program development from concept to implementation
  • Annual program maintenance investment
• Chapter 2:
  • Percentage of companies that have non-branded disease awareness campaigns
  • Percentage of companies leveraging various media channels
  • Examples of pharmaceutical adherence tools
  • Companies' ratings of program challenges
  • Percentage of companies with outcome measurements in place to measure ROI
• Chapter 3:
  • Percentage of average drugs' foregone sales due to adherence issues
  • Brand websites most visited by physicians
• Chapter 4 Contains 18 Program Profiles, Which Each Contain The following Metrics and Graphics:
  • Program background information: condition status, global launch, brand/therapeutic area peak annual sales
  • Percentage of patients compliant at various treatment stages
  • Cost to attain a new patient vs. cost to retain an existing patient
  • Percentage of current overall marketing budget spent on patient adherence/disease management
  • Program funding sources
  • Development budget vs. annual maintenance budget
  • Percentage of development budget spent on various program activities
  • Media channels leveraged in campaign
  • Percentage of development budget that was outsourced
  • Staff support at various program stages
  • Timing of key program development activities
  • ROI measurements